<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02559882</url>
  </required_header>
  <id_info>
    <org_study_id>EK2015_0045</org_study_id>
    <nct_id>NCT02559882</nct_id>
  </id_info>
  <brief_title>How to Test Success of a Renal Denervation</brief_title>
  <official_title>Testing Effectiveness of Renal Denervation in Patients With Therapy-resistant Hypertension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aimed to assess the success of a clinically indicated renal denervation by
      different tests and correlate the results of the tests with the clinical outcome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We aim to test the response to adenosine infusion, cold pressure test, flow mediated dilation
      of renal artery before and after a clinical indicated renal denervation. Renal Denervation is
      not a study intervention
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2015</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Response to adenosine infusion, cold pressure test, flow mediated dilation of renal artery before and 1 year after renal denervation B</measure>
    <time_frame>chronic</time_frame>
    <description>Changes in blood pressure and heart rate, in renal artery diameter and flow during adenosine infusion before and 1 year after renal denervation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>lood pressure (office and 24-hour blood pressure), laboratory parameter before and 12 months after catheter-based renal denrevation</measure>
    <time_frame>chronic</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood pressure (office and 24-hour blood pressure), laboratory parameter before and 1, 3, 6 months after catheter-based</measure>
    <time_frame>chronic</time_frame>
    <description>Blood pressure (office and 24-hour blood pressure), laboratory parameter before and 1, 3, 6 months after catheter-based</description>
  </secondary_outcome>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Hypertension, Resistant to Conventional Therapy</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patient with therapy resistant hypertension and clinical indication for renal nerve
        ablation
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Male and female patients 18 years to 85 years of age, with a diagnosis of re-sistant
        hypertension (office sitting blood pressure &gt;140/90 mmHg and 24-hour blood pressure &gt;130/80
        mmHg in patients treated with at least three antihypertensive drugs including a diuretic)
        and a clinical indication for a renal denervation.

        Exclusion Criteria:

          -  Secondary cause of hypertension

          -  Anatomical contraindication to renal denervation (renal artery diameter less than 4 mm
             or more than 8 mm), multiple renal artery, length to bifurcation less than 2 cm

          -  Heart failure (normal ejection fractions on echocardiography and no clinical signs and
             symptoms of heart failure).

          -  Alcohol or drug abuse,

          -  Malignancy (unless healed or remission &gt; 5 years)

          -  Pregnancy

          -  Know allergy to contrast medium

          -  Participation in another study within the last month
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Isabella Sudano, MD Phd</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Heart Center Cardiology University Hospital Zurich</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Isabella Sudano, MD PhD</last_name>
    <phone>0041 44 255 5841</phone>
    <email>isabella.sudano@usz.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Silviya Cantatore</last_name>
    <phone>0041 44 2552280</phone>
    <email>silviya.cantatore@usz.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Cardiology University Heart Center Zurich University Hospital</name>
      <address>
        <city>Zurich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isabella Sudano, MD PhD</last_name>
      <phone>0041 44 2555841</phone>
      <email>isabella.sudano@usz.ch</email>
    </contact>
    <contact_backup>
      <last_name>Silviya Cantatore, RN</last_name>
      <phone>0041 44 255 22 80</phone>
      <email>silviya.cantatore@usz.ch</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 24, 2015</study_first_submitted>
  <study_first_submitted_qc>September 24, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 25, 2015</study_first_posted>
  <last_update_submitted>October 24, 2017</last_update_submitted>
  <last_update_submitted_qc>October 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Coronary Vasospasm</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

